Journal of Clinical Oncology Archives - Agendia

Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline
Gallery
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline

Adjuvant, Evidence, MINDACT

Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline

PUBLICATION: Journal of Clinical Oncology 37, no. 22 (August 01, Read More

kevin2024-03-25T08:47:41-07:00August 1st, 2019|Adjuvant, Evidence, MINDACT|

Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor–Positive Early Breast Cancer: Results of a Prospective Cohort Study
Gallery
Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor–Positive Early Breast Cancer: Results of a Prospective Cohort Study

Adjuvant, Evidence, MammaPrint

Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor–Positive Early Breast Cancer: Results of a Prospective Cohort Study

PUBLICATION: Journal of Clinical Oncology 35, no. 24 (August 20, Read More

kevin2024-03-25T09:02:54-07:00August 20th, 2017|Adjuvant, Evidence, MammaPrint|

Clinical Application of the 70-gene Profile: The MINDACT Trial
Clinical Application of the 70-gene Profile: The MINDACT Trial

Adjuvant, Evidence, MammaPrint, MINDACT

Clinical Application of the 70-gene Profile: The MINDACT Trial

PUBLICATION: J Clin Oncol. 2008 Feb 10;26(5):729-35. doi: 10.1200/JCO.2007.14.3222. AUTHORS: Read More

kevin2024-03-07T10:56:53-08:00February 11th, 2008|Adjuvant, Evidence, MammaPrint, MINDACT|

Gene Expression Profiling of Breast Cancer: A New Tumor Marker
Gene Expression Profiling of Breast Cancer: A New Tumor Marker

Evidence, MammaPrint, Other, Validation

Gene Expression Profiling of Breast Cancer: A New Tumor Marker

PUBLICATION: Journal of Clinical Oncology March 10, 2005 23:8, 1631-1635 Read More

kevin2024-03-25T11:19:45-07:00March 10th, 2005|Evidence, MammaPrint, Other, Validation|

Agendia precision oncology

Quick Links

Our Tests
Resources
Landmark Trials
Order A Test
For Patients

Legal

Privacy Policy
Legal & Compliance
Terms & Conditions
Licenses & Accreditations
Code of Conduct

Contact

For the US, Puerto Rico, Canada
and South America
Agendia Inc. USA, 22 Morgan, Irvine, CA 92618
(888) 321-2732
customercare@agendia.com

For outside the Americas
Agendia NV, Radarweg 60, 1043 NT Amsterdam, The Netherlands
+31 (0)20 462 1510
customerservice@agendia.com

©2024 Agendia. All rights reserved. MammaPrint and Blueprint are registered trademarks of Agendia, Inc.